Medicines in Development for Children 2020 Report
Researching and developing innovative and therapeutically appropriate medicines for children and infants is an important priority for America’s biopharmaceutical research companies. The biopharmaceutical industry is currently developing nearly 600 medicines to meed the unique needs of pediatric patients.
Interested in reading more on the Medicines in Development for Children 2020 Report?
Get your free copy of the report now.